Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency
2011

Targeted Delivery of Gelonin to Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Yuan Xiaoqin, Lin Xinjian, Manorek Gerald, Howell Stephen B

Primary Institution: University of California-San Diego

Hypothesis

Can activatable cell penetrating peptides enhance the delivery of gelonin to claudin-expressing cancer cells?

Conclusion

The study found that while a claudin ligand can deliver gelonin into cancer cells, the delivered molecules often remain trapped in intracellular vesicles.

Supporting Evidence

  • Claudins 3 and 4 are over-expressed in many tumors, making them targets for therapy.
  • The addition of a poly-arginine sequence increased cytotoxicity but lost selectivity for claudin-expressing cells.
  • Chloroquine treatment increased the cytotoxicity of the fusion protein.

Takeaway

Researchers are trying to find better ways to deliver cancer-fighting drugs directly into tumor cells, but sometimes the drugs get stuck inside the cells and can't do their job.

Methodology

The study involved constructing various fusion proteins of gelonin and claudin-targeting peptides, testing their internalization and cytotoxicity in ovarian cancer cells.

Limitations

The study did not achieve effective release of gelonin from endosomal compartments after delivery.

Digital Object Identifier (DOI)

10.1186/1471-2407-11-61

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication